Abstract:Abstract Background: Endometrial cancer (EC) patients with lymph node (LN) metastasis have poor prognosis. However, the potential biomarkers that predict LN metastasis and the molecular mechanism of tumor-induced peritumoral lymphangiogenesis have not been well explored. Cancer-secreted exosomal miRNAs are emerging mediators of cell-cell communication in the tumor environment.Methods: Exosomes were isolated with a differential centrifugation method and confirmed by Transmission electron microscopy, NanoSight analysis, and Western blot. MicroRNA (miRNA) sequencing of exosomes derived from EC patients and healthy donors were performed. FISH and qRT-PCR were used to detect the indicated miRNA expression. Exosomal miRNA transferred to cells were confirmed by immunofluorescence and confocal microscope. siRNA and plasmid transfections as well as viral infection were performed to manipulate gene expression. A series of in vitro and in vivo phenotype experiments (tube formation, migration, and popliteal LN metastasis model) were performed to investigate the role of indicated miRNA in EC. RNA sequencing was used to select the underlying transcription factor, and luciferase activity assay and chromatin immunoprecipitation were performed to elucidate the molecular mechanisms. Results: Our data showed that serum exosomal miR-26a-5p was significantly reduced in EC patients, and its level was positively associated with LN metastasis. Loss of miR-26a-5p promoted the migratory and invasive abilities of EC cells, and miR-26a-5p could be transferred from EC cells-secreted exosomes into human lymphatic endothelial cell (HLEC). Mechanistically, miR-26a-5p could regulate LEF1/c-myc/VEGFA axis via binding to its direct downstream target lymphoid enhancer binding factor 1 (LEF1), consequently promoting HLEC tube formation and migration in vitro, facilitating lymphangiogenesis and LN metastasis in vivo. Re-expression and knockdown of LEF1 could respectively promote and rescue the effects induced by exosomal miR-26a-5p. Moreover, we demonstrated that transcriptional factor EB (TFEB) directly induced miR-26a-5p expression.Conclusions: Our results show that exosomal miR-26a-5p/LEF1/c-myc/VEGFA axis is dysregulated and plays a critical role in LN metastasis and exosomal miR-26a-5p may be used as a blood-based biomarker for EC patients with LN metastasis.

Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer

Exosomal Lncrna SCIRT/miR-665 Transferring Promotes Lung Cancer Cell Metastasis Through the Inhibition of HEYL

[Advances in the Role of Exosome-Derived Long Non-Coding RNAs in Hepatocellular Carcinoma].

Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer

Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms

Exosomal lncRNA Mir100hg derived from cancer stem cells enhance glycolysis and promote metastasis of lung adenocarcinoma through mircroRNA-15a-5p/31-5p

Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer

Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets

Cancer cell-derived exosomes promote NSCLC progression via the miR-199b-5p/HIF1AN axis

Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances

Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis Through Regulating CCL2 Expression in Lung Epithelial Cells

M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942

Non-small lung cancer cells-derived exosome miR-3157-3p primes pre-metastatic niche by inducing angiogenesis and vascular permeability

Tumor‐derived exosomes: Key players in non‐small cell lung cancer metastasis and their implication for targeted therapy

Cancer-Secreted Exosomal MiR-620 Inhibits ESCC Aerobic Glycolysis via FOXM1/HER2 Pathway and Promotes Metastasis

Identification of metastasis-related long non-coding RNAs in lung cancer through a novel tumor mesenchymal score

Downregulation of Exosomal Mir-26A-5p Promotes Lymphangiogenesis and Lymphatic Metastasis in Endometrial Cancer

Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential

Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis.

Alterations in exosomal miRNA profile upon epithelial-mesenchymal transition in human lung cancer cell lines

Tumor-derived Exosome Promotes Metastasis via Altering its Phenotype and Inclusions